Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1)

Abstract

We have analysed the effects of p53 and of the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1) located on chromosome 16 on glucocorticoid- and radiation-induced in vivo apoptosis of thymocytes. For those analyses, we used Rapop1 semicongenic mice heterozygous for the STS and BALB/cHeA alleles in the chromosomal segment containing Rapop1 in the BALB/cHeA background, mice bearing a p53 deficient allele in the BALB/cHeA background and the genetic crosses between these mice. The p53 wild type mice with a STS/A allele at the Rapop1 locus were less susceptible to both radiation- and glucocorticoid-induced apoptosis than those with homozygous BALB/cHeA alleles at this locus. Surprisingly, glucocorticoid-induced apoptosis was enhanced in the p53 hemizygous mice and considerably increased in the p53 nullizygous mice. In contrast, a sizable reduction of radiation-induced apoptosis was seen in the p53 hemizygous mice. The low susceptiblity to glucocortocoid-induced apoptosis linked to the STS allele of Rapop1 was less pronounced in the p53 hemizygous mice and a diminished effect of Rapop1 on radiation-induced apoptosis was seen in these mice. Although it remains to be established whether the genes modulating glucocortocoid-induced apoptosis are identical to p53 and Rapop1, our data suggest that p53 and Rapop1 may participate in glucocorticoid-induced apoptosis of thymocytes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Auphan N, DiDonato JA, Rosette C, Helmberg A and Karin M. . 1995 Science 270: 286–290.

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature (London) 362: 849–852.

  • Demant P and Hart AAM. . 1986 Immunogenetics 24: 416–422.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. . 1992 Nature (London) 356: 215–221.

  • Gavrieli Y, Sherman Y and Ben-Sasson SA. . 1992 J. Cell. Biol. 119: 493–501.

  • Goodrow TL, Storer RD, Leander KR, Prahalada SR, van Zwieten MJ and Bradley MO. . 1992 Mol. Carcinog. 5: 9–15.

  • Guidos CJ, Williams CJ, Grandal I, Knowles G, Huang MTF and Danska JS. . 1996 Genes. Dev. 10: 2038–2054.

  • Iwata M, Hanaoka S and Sato K. . 1991 Eur. J. Immunol. 21: 643–648.

  • Kerppola TK, Luk D and Curran T. . 1993 Mol. Cell. Biol. 13: 3782–3791.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Levin AJ. . 1997 Cell 88: 323–331.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. . 1993 Nature (London) 362: 847–849.

  • Marchetti P, Casted M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M and Kroemer G. . 1996 J. Exp. Med. 184: 1155–1160.

  • Mori N, Okumoto M, Morimoto J, Imai S, Matsuyama T, Takamori Y and Yagasaki O. . 1992 Int. J. Radiat. Biol. 62: 53–159.

  • Mori N, Okumoto M, van der Valk MA, Imai S, Haga S, Esaki K, Hart AM and Demant P. . 1995a Genomics 25: 609–614.

  • Mori N, Okumoto M, Hart AAM and Demant P. . 1995b Genomics 30: 553–557.

  • Scheinman RI, Cogswell PC, Lofquist AK and Baldwin Jr AS. . 1995 Science 270: 283–286.

  • Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H and Tsujimoto Y. . 1996 Oncogene 13: 21–29.

  • Stassen AP, Groot PC, Eppig JT and Demant P. . 1996 Mamm. Genome 7: 55–58.

  • Vacchio MS and Ashwell JD. . 1997 J. Exp. Med. 185: 2033–2038.

  • van Wezel T, Stassen AP, Moen CJ, Hart AA, van der Valk MA and Demant P. . 1966 Nature Genet. 14: 468–470.

  • Weil MM, Xia X, Lin Y, Stephens LC and Amos CI. . 1997 Genomics 45: 626–628.

  • Wyllie AH. . 1980 Nature (London) 284: 555–556.

  • Yu C, Yap N, Chen D and Cheng S. . 1997 Cancer Lett. 116: 191–196.

Download references

Acknowledgements

We thank Drs LA Donehower and A Bradley for their kind gift of p53 deficient mice. We also thank Drs J Allen, GG Gomez and AAM Hart of The Netherlands Cancer Institute for their helpful discussion during preparation of this paper. This publication is partly supported by a research subsidy from the Showa Shell Sekiyu Environmental Research Foundation to Dr N Mori, by a grant from the Japan Atomic Energy Research Institute, by the contract of the Nuclear Safety Research Association to Dr M Okumoto, and by a grant from the Dutch Cancer Foundation to Dr P Demant.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mori, N., Yamate, J., Stassen, A. et al. Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). Oncogene 18, 4282–4285 (1999). https://doi.org/10.1038/sj.onc.1202719

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202719

Keywords

Search

Quick links